NY Times Front Page Article Vaccine Success Muffl
Post# of 148250
(Total Views: 728)
Posted On: 01/31/2021 8:50:31 AM
NY Times Front Page Article
Vaccine Success Muffles Missteps on Treatment
https://www.google.com/amp/s/www.nytimes.com/...s.amp.html
Chronicles the failed efforts of therapeutics! Sadly no mention of Leronlimab. Focus is still on fighting the virus, early on, now with repurposed existing drugs, and government funded large trials to test them. Unfortunate that they still don’t get it, that the body can deal with the virus if it can stay healthy.
“I blame myself to some extent,” said Dr. Woodcock, who has overseen the federal government’s efforts to develop Covid drugs.
She hopes to tame the chaos with a new effort from the Biden administration. In the next couple of months, she said, the government plans to start large and well organized trials for existing drugs that could be repurposed to fight Covid-19. “We are actively working on that,” Dr. Woodcock said.
“This effort will be unlikely to provide therapeutics in 2021,” Dr. Francis Collins, the head of of the N.I.H., said in a statement. “ If there is a Covid-24 or Covid-30 coming, we want to be prepared.”
Vaccine Success Muffles Missteps on Treatment
https://www.google.com/amp/s/www.nytimes.com/...s.amp.html
Chronicles the failed efforts of therapeutics! Sadly no mention of Leronlimab. Focus is still on fighting the virus, early on, now with repurposed existing drugs, and government funded large trials to test them. Unfortunate that they still don’t get it, that the body can deal with the virus if it can stay healthy.
“I blame myself to some extent,” said Dr. Woodcock, who has overseen the federal government’s efforts to develop Covid drugs.
She hopes to tame the chaos with a new effort from the Biden administration. In the next couple of months, she said, the government plans to start large and well organized trials for existing drugs that could be repurposed to fight Covid-19. “We are actively working on that,” Dr. Woodcock said.
“This effort will be unlikely to provide therapeutics in 2021,” Dr. Francis Collins, the head of of the N.I.H., said in a statement. “ If there is a Covid-24 or Covid-30 coming, we want to be prepared.”
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼